Government Briefs

Thinking Small Presidential science adviser Allan Bromley says that the president's 1992 budget will provide succor--at least on paper--for those who believe that money to support small academic science is being diverted to megaprojects and large centers linked to industry. Bromley made that promise during a speech last month at the annual R&D symposium sponsored by the American Association for the Advancement of Science. Referring to his meetings with Richard Darman, director of the Office

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Thinking Small Presidential science adviser Allan Bromley says that the president's 1992 budget will provide succor--at least on paper--for those who believe that money to support small academic science is being diverted to megaprojects and large centers linked to industry. Bromley made that promise during a speech last month at the annual R&D symposium sponsored by the American Association for the Advancement of Science. Referring to his meetings with Richard Darman, director of the Office of Management and Budget, Bromley said "we have agreed that the 1992 budget will give special attention to the support of small science and young investigators." Asked afterward how such support might be manifested, Bromley said that "I hope that there will be prose in the text [of the budget message] that will encourage individual agencies to pay more attention to this problem." Bromley added that scientists also should look at the budgets of individual ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies